Stay updated on Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.

Latest updates to the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, which still displays a 403 error. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study record content and attachments; the site’s header/footer remain, but the study details are blocked from access.SummaryDifference16%

- Check44 days agoChange DetectedThe revision label on the page was updated from v3.6.6 to v3.7.0, representing a new version of the study page metadata. It does not alter the displayed study information or functionality.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a software version update to the ClinicalTrials.gov interface rather than any changes to the study data.SummaryDifference0.0%

- Check65 days agoChange DetectedFunding attribution updated to include '2017 ( U.S. NIH Grant/Contract )' in the study's identifiers, linking the U.S. NIH funding to the project.SummaryDifference0.0%

Stay in the know with updates to Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.